AKT2 and type 1 diabetes mellitus: AKT2 signaling is renoprotective in T1D by enhancing antioxidant signaling with AMPK activation (Cheng et al., 2020) and promotes podocyte viability in chronic kidney disease (Canaud et al., 2013).